A double-chambered right ventricle is a relatively uncommon congenital cardiac defect characterized by the presence of anomalous muscle bundles dividing the right ventricle into a high-pressure proximal chamber and a low-pressure distal chamber. This pathology is often wrongly diagnosed in adult patients. We report the first case of a patient with double-chambered right ventricle associated with a mural and pulmonic valve endocarditis caused by Streptococcus parasanguis diagnosed with two-dimensional echocardiography. During the course of treatment, the patient suffered from a septic pulmonary embolism, and subsequently required surgical intervention, which confirmed the echocardiographic findings.
OBJECTIVE:To report the case of a patient with pericardial lipoma diagnosed unexpectedly during heart failure investigation with diagnosis definitive after surgery.
METHODS:A review of medical records and analysis of photographic records of the diagnostic exams, to which the patient was submitted, were performed and a literature review was carried out.
FINAL CONSIDERATIONS:Cardiac lipomas are very rare neoplasms in the population. Often patients with these tumors are asymptomatic or with nonspecific symptomatology. Echocardiographic diagnosis is sometimes quite difficult. Surgical treatment is reserved for cases that bring discomfort or risk to the patient. In the current case, the surgical procedure had therapeutic and diagnostic importance. This case demonstrates the importance of associating diagnostic methods in the search for an accurate diagnosis. This patient was medicated and had side effects of the therapy, because she had the diagnosis initially given only by the chest X-ray.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.